CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION INTOLERANT TO ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ALTERNATIVE TRIAL